This project seeks to answer some basic questions concerning the spinal mechanisms of analgesia. The first goal of the studies is to characterize the action of several putative neurotransmitters or nociceptive spinal neurons projecting to the brain. Neurophysiological studies of unit activity of identified spinothalamic projection neurons in anesthetized rats will quantify their responses to thermal stimulation and to a putative primary afferent fiber neurotransmitter, substance P. Subsequent experiments will evaluate the effects of other neurotransmitters (enkephalin analogs and monoamines), opiate analgesics (eg., morphine), heterocyclic antidepressant agents (eg., protryptyline), and their combinations on responses to these stimuli. Behavioral experiments designed to monitor ascending spinal systems in unanesthetized mice using intrathecal injections of these agents will address the behavioral relevance of the neurophysiological data. The second goal of this project is to examine alterations in the spinal pharmacology of the above substances which might accompany opiate tolerance and dependence. Such alterations appear to change the interaction between brain areas activated by opiate and spinal systems affected by opiates. Selected experiments from those described above will be repeated in mice and rats made tolerant to and dependent on opiates. A better understanding of the pharmacological consequences of spinal tolerance/dependence will help us in the design of analgesic combinations with reduced liabilities and of techniques for the moderation of opiate withdrawal. This project is important because it investigates the pharmacology of a system -- the spinothalamic projection system -- which has been clearly identified to be important to human pain perception, but which has not been previously studied pharmacologically.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA001933-06
Application #
3207044
Study Section
(DABA)
Project Start
1978-09-30
Project End
1988-12-31
Budget Start
1987-01-01
Budget End
1988-12-31
Support Year
6
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Riedl, Maureen S; Schnell, Stephen A; Overland, Aaron C et al. (2009) Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn. J Comp Neurol 513:385-98
Stone, Laura S; Wilcox, George L (2004) Alpha-2-adrenergic and opioid receptor additivity in rat locus coeruleus neurons. Neurosci Lett 361:265-8
Stone, Laura S; Vulchanova, Lucy; Riedl, Maureen S et al. (2004) Effects of peripheral nerve injury on delta opioid receptor (DOR) immunoreactivity in the rat spinal cord. Neurosci Lett 361:208-11
Laughlin, Tinna M; Tram, Kevin V; Wilcox, George L et al. (2002) Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. J Pharmacol Exp Ther 302:1168-75
Fairbanks, Carolyn A; Stone, Laura S; Kitto, Kelley F et al. (2002) alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther 300:282-90
Laughlin, T M; Bethea, J R; Yezierski, R P et al. (2000) Cytokine involvement in dynorphin-induced allodynia. Pain 84:159-67
Fairbanks, C A; Nguyen, H O; Grocholski, B M et al. (2000) Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology 93:765-73
Fairbanks, C A; Posthumus, I J; Kitto, K F et al. (2000) Moxonidine, a selective imidazoline/alpha(2) adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice. Pain 84:13-20
Fairbanks, C A; Schreiber, K L; Brewer, K L et al. (2000) Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A 97:10584-9
Fairbanks, C A; Wilcox, G L (1999) Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther 290:403-12

Showing the most recent 10 out of 35 publications